| |
Univariable
|
Multivariable
|
|---|
|
No
|
Yes
|
OR (95% CI)
|
P-value
|
OR (95% CI)
|
P-value
|
|---|
|
Group
|
|
Active
|
23 (69.7%)
|
10 (30.3%)
|
1.81 (0.57,5.78)
|
0.315
|
1.97 (0.58,6.69)
|
0.279
|
|
Placebo
|
25 (80.6%)
|
6 (19.4%)
|
Reference
|
Reference
|
|
Sex
|
|
Female
|
34 (79.1%)
|
9 (20.9%)
|
Reference
|
0.286
|
Reference
|
0.155
|
|
Male
|
14 (66.7%)
|
7 (33.7%)
|
1.89 (0.59,6.07)
|
2.81 (0.68,11.65)
|
|
Marital Status
|
|
Single
|
17 (70.8%)
|
7 (29.2%)
|
1.42 (0.45,4.86)
|
0.552
|
0.48 (0.18,3.99)
|
0.823
|
|
Married
|
31 (77.5%)
|
9 (22.5%)
|
Reference
|
Reference
|
|
Duration of Migraine
|
|
≤2 years
|
26 (72.2%)
|
10 (27.8%)
|
1.41 (0.44,4.50)
|
0.562
|
0.94 (0.25,3.51)
|
0.992
|
|
> 2 years
|
22 (78.6%)
|
6 (21.4%)
|
Reference
|
Reference
|
|
Age (mean ± SD)
|
37.29 ± 9.42
|
33.81 ± 8.89
|
0.96 (0.89,1.02)
|
0.20
|
0.97 (0.87,1.07)
|
0.494
|
|
BMI (mean ± SD)
|
24.25 ± 3.03
|
23.14 ± 2.99
|
0.88 (0.72,1.08)
|
0.21
|
0.88 (0.68,1.16)
|
0.369
|
- BMI Body–mass index, SD Standard deviation, CI Confidence interval
